Logo

Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US

Share this

Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US

Shots:

  • Qiagen reports the launch of the Access Anti-SARS-CoV-2 Total test that runs on a portable device and provides accurate results on Total Ig Abs (IgA- IgM- IgG) in 10mins. The device can process up to 8 samples simultaneously or up to 32 tests/hour
  • The test was developed in collaboration with Ellume- following the US FDA’s EUA submission. The companies plan to launch it in the US in Aug’2020 while anticipates the CE-IVD marking in the EU with the initiation of commercialization in other markets in coming weeks
  • The test is performed on eHub & eStick system provides rapid qualitative serological in-vitro detection of total antibodies to SARS-CoV-2 in plasma & serum and has demonstrated 100% sensitivity & specificity

­ Ref: Qiagen | Image: Fierce Biotech

Related News: Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions